ArticleProceedings of the National Academy of Sciences of the United States of America2019

In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease.

Brian Leei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.